Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-066176

Neurogene Inc. · NGNE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kamran Alam
Officer — CFO, Vice President Finance
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 8:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001404644

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 12, 2015M8,246$5.76A8,246D
Common StockAug 12, 2015M20,833$5.76A29,079D
Common StockF1Aug 12, 2015S29,079$18.67D0D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$5.76Aug 12, 2015M8,246D—May 29, 2022Common Stock8,2462,170D
Stock Option (Right to Buy)F3$5.76Aug 12, 2015M20,833D—Aug 22, 2021Common Stock20,8330D

Explanation of responses